📈 What Do 14 Device Approvals Mean for LatAm?
🌍 Can Latin America Outpace U.S. in Trial Speed?
🏥 Inside the Hospital Powering On-Demand Isotopes
🌎 Why Are MedTech Trials Moving to Latin America?
Oxford, UK and Panama City, Panama — Newrotex Ltd., an Oxford-based medical technology company, today announced the successful first-in-human implantation of its flagship nerve repair technology, SilkAxons™. The procedure marks a world-first for a technology designed to bridge large peripheral nerve gaps beyond the capabilities of currently available solutions. The procedure was performed by the s
Is Australia Quietly Leading in Spine Trials? 🇦🇺
Mexico's COFEPRIS is introducing a new Abbreviated Regulatory Pathway for medical devices and drugs. This streamlined process aims to expedite approvals by recognizing authorizations from trusted international regulators. Key Points: Why It Matters: This pathway could transform Mexico into a priority launch market for innovative medical devices, potentially accelerating patient access to cutting-edge treatments.
🛠️ Panama Fast-Tracks 3D Implants in Just 60 Days
🇨🇴 Ready for Colombia’s clinical trial revolution?
Cookie policies play a crucial role in digital privacy and user experience. Understanding how websites use cookies can help you make informed decisions about your online data. Key Points: Why It Matters: Knowing your cookie preferences empowers you to control your digital footprint and customize your online experience.
🇧🇷 Inside Brazil’s MedTech Momentum
Cookie policies play a crucial role in website functionality and user privacy. Understanding their purpose and types can help users make informed decisions about their online experience. Key Points: Why It Matters: Informed cookie choices empower users to balance personalized browsing experiences with data privacy concerns.
🚀 First-in-Human Trials: Why LATAM Is Gaining Speed
Hospital Internacional de Colombia (HIC) is set to obtain GCSA certification, marking a significant milestone for clinical research in Latin America. This development strengthens HIC's partnership with bioaccess®, the leading first-in-human CRO in the region. Key Points: Why It Matters: This certification enhances the quality and credibility of clinical trials conducted in Latin America, offering medtech and biopharma companies access to world-class research facilities and expertise.
🔬 Where Smart Trials Meet Rising Global Standards
The Helsinki Report outlines crucial ethical guidelines for clinical research directors conducting studies with human subjects. These insights ensure participant safety, maintain research integrity, and promote transparency in medical trials. Key Points: Why It Matters: Adhering to these ethical principles safeguards participants, builds trust in clinical research, and accelerates the development of life-saving medical innovations.